PMC3565880_01
Effect of temozolomide on pelvic metastasis. A: before the beginning of treatment. B: after 11 months of treatment.
1752-1947-7-29-1.jpg
PMC3565880_01_1752-1947-7-29-1.jpg
F1
Despite the negative status of O6-methylguanine-deoxyribonucleic acid (DNA)-methyltransferase promoter methylation (this kind of test is performed for patients with glioblastoma multiforme to predict response to temozolomide), a rapid response to therapy was observed with a reduction in the pelvic lesion, resolution of pain and removal of the nephrostomies (Figures 1 and 2).
Effect of temozolomide on one of the lung metastases. A: before the beginning of treatment. B: after 11 months of treatment.
1752-1947-7-29-2.jpg
PMC3565880_01_1752-1947-7-29-2.jpg
F2
Despite the negative status of O6-methylguanine-deoxyribonucleic acid (DNA)-methyltransferase promoter methylation (this kind of test is performed for patients with glioblastoma multiforme to predict response to temozolomide), a rapid response to therapy was observed with a reduction in the pelvic lesion, resolution of pain and removal of the nephrostomies (Figures 1 and 2).